Individuals with IDD are often excluded from health-related research. Exclusion from research leads to reduced quality of health care and unknown treatment effectiveness.

The special virtual event from 6 to 7:30 p.m. will feature TRIAD leaders past and present.

The goal of the wearable technology is to improve behavioral assessment of children with intellectual and developmental disabilities by predicting the precursors of problem behaviors and using that information to adjust therapeutic approaches.

Vanderbilt University Medical Center received a $13 million Department of Defense grant to lead a multisite clinical trial that will evaluate repurposed FDA-approved drugs as treatment options for patients with Rett syndrome.

Nineteen leaders have been named as holders of directorships at Vanderbilt University Medical Center.